Billionaire David Tepper of Appaloosa Dumped His Fund's Stake in Broadcom and 14X'd His Position in a Polarizing Healthcare Stock

Billionaire investor David Tepper's Appaloosa Management made significant portfolio adjustments in Q2, notably selling its entire 130,000-share position in AI networking specialist Broadcom (AVGO) after a rapid, profitable trade, potentially driven by profit-taking, valuation concerns, and a cautious outlook on a potential AI bubble. Concurrently, Appaloosa dramatically increased its stake in underperforming healthcare giant UnitedHealth Group (UNH) by 1,300%, despite its recent struggles with Medicare Advantage costs and a DOJ probe, signaling a contrarian bet on the company's corrective actions and long-term value.

Analysis

Billionaire investor David Tepper's Appaloosa Management significantly rebalanced its portfolio in Q2, notably exiting its entire 130,000-share position in AI networking specialist Broadcom (AVGO). This rapid divestment, occurring within a single quarter, suggests a tactical move to lock in substantial profits, potentially around 60% from late March to late June, deviating from Appaloosa's typical 29-month holding period.

The AVGO sale was likely influenced by valuation concerns, as Broadcom's forward P/E ratio surged from ~18 in late Q1 to 35 by October 10, significantly exceeding its historical average. Tepper may also be signaling caution regarding a potential "AI bubble," recognizing historical patterns of growth rate slowdowns for new technologies, even while maintaining exposure to other AI plays.

Conversely, Appaloosa dramatically increased its stake in UnitedHealth Group (UNH) by 1,300% in Q2, moving from 175,000 to 2,450,000 shares. This contrarian bet comes despite UNH's 30% year-to-date decline as of October 10 and ongoing challenges, including higher Medicare Advantage costs, a DOJ probe, and a reduced 2025 profit forecast.

Tepper's conviction in UNH appears to hinge on management's proactive measures, such as discontinuing Medicare Advantage plans in 16 markets to mitigate costs, and the company's inherent premium pricing power. The strength of its Optum segment, UnitedHealth's fastest-growing and highest-margin division, also provides a strong foundation for future margin improvement, potentially making the current valuation attractive if Medicare Advantage concerns are resolved.

Key Decisions for Investors

• Investors should closely monitor Broadcom's (AVGO) valuation metrics, particularly its forward P/E, and assess the broader AI sector for signs of overheating, aligning with Tepper's profit-taking strategy.
• Evaluate UnitedHealth Group's (UNH) management actions regarding Medicare Advantage costs and the performance of its Optum segment, as Tepper's significant stake increase suggests a contrarian view on its long-term value despite current challenges.
• Consider incorporating a balanced approach of tactical profit-taking in high-growth sectors and contrarian bets on undervalued, fundamentally sound companies, mirroring Appaloosa's demonstrated strategy.